Skip to main content

Advertisement

Figure 1 | Retrovirology

Figure 1

From: A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

Figure 1

V3 loop amino acid alterations responsible for resistance to MVC by viruses harbored by subjects 17 and 24. The V3 loop alterations shown in bold face were demonstrated to be associated with resistance to MVC by 17-Res and 24-Res Envs [47, 56]. Dots indicate residues identical to the parental sensitive Envs, and dashes indicate gaps. The numbering is based of the HXB2 Env amino acid sequence.

Back to article page